Many researchers are interested in utilizing state-of-the-art technologies such as microarray-basedtranscriptomic and genomic analyses to attempt to dissect molecular profiles. Within the past decade wehave witnessed significant advancements in research that are directly associated with the output of thegenome sequencing endeavor. The results of these achievements provide hope to investigators researchingcomplex diseases like cancer. Alterations in genes causing these diseases may result in one or severalgenes having aberrant genomic profiles or even hundreds to thousands of genes with perturbed function.This can result in a mishmash of genomic profiles that is difficult to sort through, presenting a challenge toresearchers attempting to elucidate the cause and effect of cancer.To assist BCMCC investigators with these issues, the Genomic Profiling Resource will integrate two existingBaylor College of Medicine (BCM) facilities to provide state-of-the-art access to transcriptional or genomicprofiling using microarray technology. The Resource utilizes spotted glass microarrays and the commerciallyavailable Affymetrix GeneChip platform and offers expert advice in experimental design, data analysis, andbioinformatics, as well as access to computing hardware and software. Services offered by the Resourceinclude sample quality control, expression profiling with microarrays, quantitative (real time) PCR, access toa cDNA clone respository, comparative genomic hybridization on spotted arrays, SNP genotyping utilizingAffymetrix GeneChips, data analysis, training, and workshops. Led by Drs. Lisa White and Ching Lau, thisCore will provide a cost-effective resource for Cancer Center researchers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
1P30CA125123-01
Application #
7514637
Study Section
Subcommittee G - Education (NCI)
Project Start
2007-07-01
Project End
2010-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
1
Fiscal Year
2007
Total Cost
$112,819
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Xing, Zhen; Zhang, Yanyan; Liang, Ke et al. (2018) Expression of Long Noncoding RNA YIYA Promotes Glycolysis in Breast Cancer. Cancer Res 78:4524-4532
Creighton, Chad J (2018) The clinical applications of The Cancer Genome Atlas project for bladder cancer. Expert Rev Anticancer Ther 18:973-980
Guarducci, Cristina; Bonechi, Martina; Benelli, Matteo et al. (2018) Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer. NPJ Breast Cancer 4:38
Byrd, Tiara T; Fousek, Kristen; Pignata, Antonella et al. (2018) TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer. Cancer Res 78:489-500
Kho, Jordan; Tian, Xiaoyu; Wong, Wing-Tak et al. (2018) Argininosuccinate Lyase Deficiency Causes an Endothelial-Dependent Form of Hypertension. Am J Hum Genet 103:276-287
Chiang, Angie C A; Fowler, Stephanie W; Savjani, Ricky R et al. (2018) Combination anti-A? treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice. J Exp Med 215:1349-1364
Szwarc, Maria M; Hai, Lan; Gibbons, William E et al. (2018) Retinoid signaling controlled by SRC-2 in decidualization revealed by transcriptomics Reproduction 156:387-395
Nguyen, Tuan M; Kabotyanski, Elena B; Dou, Yongchao et al. (2018) FGFR1-Activated Translation of WNT Pathway Components with Structured 5' UTRs Is Vulnerable to Inhibition of EIF4A-Dependent Translation Initiation. Cancer Res 78:4229-4240
Grzeskowiak, Caitlin L; Kundu, Samrat T; Mo, Xiulei et al. (2018) In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer. Nat Commun 9:2732
Liu, Yanhong; O'Brien, Jacqueline L; Ajami, Nadim J et al. (2018) Lung tissue microbial profile in lung cancer is distinct from emphysema. Am J Cancer Res 8:1775-1787

Showing the most recent 10 out of 991 publications